BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5924575)

  • 21. [Cerebral toxoplasmosis as a cause of treatable dementia in an aged patient].
    de la Fuente Fernández ; Díaz Benito JA; Rodríguez García JC; Piñeiro Gómez-Durán L
    Med Clin (Barc); 1991 Apr; 96(15):597-8. PubMed ID: 2051822
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical aspects and therapy of toxoplasmosis].
    Mohr W
    Anglo Ger Med Rev; 1969 Oct; 5():125-39. PubMed ID: 5386882
    [No Abstract]   [Full Text] [Related]  

  • 23. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
    Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
    Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of pneumocystosis and toxoplasmosis in the immunosuppressed host.
    Remington JS; Anderson SE
    Transplant Proc; 1973 Sep; 5(3):1263-70. PubMed ID: 4580723
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cerebral toxoplasmosis in the acquired immunodeficiency syndrome. Study of the clinical, radiological, and pathological findings in 10 cases].
    Bonaventura I; Romero F; Ortega A; Navarro C; Juste C; Codina Puiggrós A
    Med Clin (Barc); 1988 May; 91(1):1-6. PubMed ID: 3172889
    [No Abstract]   [Full Text] [Related]  

  • 26. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
    Couvreur J
    Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular toxoplasmosis.
    Hogan MJ
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1969; 50():1-21. PubMed ID: 4924569
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxoplasmic encephalitis.
    Luft BJ; Hafner R
    AIDS; 1990 Jun; 4(6):593-5. PubMed ID: 2386623
    [No Abstract]   [Full Text] [Related]  

  • 29. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral sudden deafness and acute acquired toxoplasmosis.
    Katholm M; Johnsen NJ; Siim C; Willumsen L
    J Laryngol Otol; 1991 Feb; 105(2):115-8. PubMed ID: 2013720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful therapy for Toxoplasma gondii myocarditis in acquired immunodeficiency syndrome.
    Grange F; Kinney EL; Monsuez JJ; Rybojad M; Derouin F; Khuong MA; Janier M
    Am Heart J; 1990 Aug; 120(2):443-4. PubMed ID: 2382625
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxoplasmosis-induced myocarditis].
    Vinogradov AV; Novikov FE; Varlamova TA; Lobzeva VI; Dutova GA
    Kardiologiia; 1978 May; 18(5):20-4. PubMed ID: 671989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
    Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contribution on the clinical aspects of acquired toxoplasmosis].
    Bühler F; Denes A
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1739-43. PubMed ID: 5707568
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxoplasmosis and myocarditis.
    Mullan DP; Henry L; Beverly JK
    Br Med J; 1968 Nov; 4(5630):559-60. PubMed ID: 5722320
    [No Abstract]   [Full Text] [Related]  

  • 36. Congestive heart failure and myocarditis after seroconversion for toxoplasmosis in two immunocompetent patients.
    Chandenier J; Jarry G; Nassif D; Douadi Y; Paris L; Thulliez P; Bourges-Petit E; Raccurt C
    Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):375-9. PubMed ID: 10898141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymyositis and toxoplasmosis.
    Samuels BS; Rietschel RL
    JAMA; 1976 Jan; 235(1):60-1. PubMed ID: 1104907
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiovascular changes in toxoplasmosis].
    Tesarová-Mágrová J; Kouba K
    Z Arztl Fortbild (Jena); 1973 Dec; 67(24):1256-9. PubMed ID: 4791817
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
    Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL
    Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotic syndrome associated with toxoplasmosis: report of seven cases.
    Toporovski J; Romano S; Hartmann S; Benini W; Chieffi PP
    Rev Inst Med Trop Sao Paulo; 2012; 54(2):61-4. PubMed ID: 22499417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.